.png)
Novocure Data Breach Lawsuit Investigation
Shamis & Gentile P.A., one of the nation's premier class action law firms specializing in data breach cases, is investigating the NovoCure data breach.
If you were affected by the data breach, your sensitive personally identifiable information may have been exposed, and you may be eligible for compensation.
About NovoCure
NovoCure is a global oncology company that develops and commercializes medical devices for cancer treatment. Founded in 2000, NovoCure is best known for its Tumor Treating Fields (TTFields) therapy.
NovoCure operates internationally, with its global headquarters in Baar, Switzerland, U.S. headquarters in Portsmouth, New Hampshire, and research and development facilities in Haifa, Israel.
What Happened?
In mid-August 2026, NovoCure became aware of unauthorized access to some of its information systems. The company responded by activating its cybersecurity response plan, implementing containment measures and hiring external cybersecurity experts to investigate the incident.
The investigation revealed that personally identifiable information (PII) belonging to current and former employees, as well as certain healthcare providers, may have been exposed.
NovoCure has stated that it will notify affected parties as required by law and anticipates additional regulatory notifications.
You May Be Entitled to Compensation
If you were affected by the NovoCure data breach, you may be eligible for compensation. Lawyers are ready to help you understand your rights and pursue a claim. To find out if you qualify and to join the lawsuit, complete the below form.
.svg)